These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18566026)

  • 1. Very early scans for demonstrating dissemination in time in multiple sclerosis.
    Tur C; Tintoré M; Rovira A; Nos C; Río J; Téllez N; Galán I; Perkal H; Comabella M; Sastre-Garriga J; Montalban X
    Mult Scler; 2008 Jun; 14(5):631-5. PubMed ID: 18566026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.
    Rovira A; Swanton J; Tintoré M; Huerga E; Barkhof F; Filippi M; Frederiksen JL; Langkilde A; Miszkiel K; Polman C; Rovaris M; Sastre-Garriga J; Miller D; Montalban X
    Arch Neurol; 2009 May; 66(5):587-92. PubMed ID: 19433658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease.
    Siva A; Saip S; Altintas A; Jacob A; Keegan BM; Kantarci OH
    Mult Scler; 2009 Aug; 15(8):918-27. PubMed ID: 19667020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
    Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis.
    Ceccarelli A; Rocca MA; Perego E; Moiola L; Ghezzi A; Martinelli V; Comi G; Filippi M
    Mult Scler; 2011 Jun; 17(6):702-7. PubMed ID: 21228024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lesion distribution in children with clinically isolated syndromes.
    Ghassemi R; Antel SB; Narayanan S; Francis SJ; Bar-Or A; Sadovnick AD; Banwell B; Arnold DL;
    Ann Neurol; 2008 Mar; 63(3):401-5. PubMed ID: 18306242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relapsing-remitting inflammatory disease of the central nervous system with normal MRI: multiple sclerosis or phenocopy in a series of 15 patients].
    Lebrun C; Bourg V; Chanalet S; Chatel M
    Rev Neurol (Paris); 2003 Apr; 159(4):397-404. PubMed ID: 12773868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barkhof magnetic resonance imaging criteria predict early relapse in pediatric multiple sclerosis.
    Neuteboom RF; Ketelslegers IA; Boon M; Catsman-Berrevoets CE; Hintzen RQ;
    Pediatr Neurol; 2010 Jan; 42(1):53-5. PubMed ID: 20004863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis.
    Gorman MP; Healy BC; Polgar-Turcsanyi M; Chitnis T
    Arch Neurol; 2009 Jan; 66(1):54-9. PubMed ID: 19139299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis.
    Di Pauli F; Reindl M; Ehling R; Schautzer F; Gneiss C; Lutterotti A; O'Reilly E; Munger K; Deisenhammer F; Ascherio A; Berger T
    Mult Scler; 2008 Sep; 14(8):1026-30. PubMed ID: 18632775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study.
    Leone MA; Bonissoni S; Collimedaglia L; Tesser F; Calzoni S; Stecco A; Naldi P; Monaco F
    Mult Scler; 2008 May; 14(4):485-93. PubMed ID: 18208889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early relapse risk after a first CNS inflammatory demyelination episode: examining international consensus definitions.
    Dale RC; Pillai SC
    Dev Med Child Neurol; 2007 Dec; 49(12):887-93. PubMed ID: 18039234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI in the diagnosis of pediatric multiple sclerosis.
    Callen DJ; Shroff MM; Branson HM; Lotze T; Li DK; Stephens D; Banwell BL
    Neurology; 2009 Mar; 72(11):961-7. PubMed ID: 19038852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
    Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
    Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
    Hurwitz BJ; Jeffery D; Arnason B; Bigley K; Coyle P; Goodin D; Kaba S; Kirzinger S; Lynch S; Mandler R; Mikol D; Rammohan K; Sater R; Sriram S; Thrower B; Boateng F; Jakobs P; Wash MB; Bogumil T
    Clin Ther; 2008 Jun; 30(6):1102-12. PubMed ID: 18640466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
    Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
    Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study.
    Gauthier SA; Glanz BI; Mandel M; Tsagkaropoulos A; Neema M; Stankiewicz J; Arora A; Duan Y; Liptak Z; Egorova S; Buckle GJ; Bakshi R; Guttmann CR; Khoury SJ; Weiner HL
    J Neurol Sci; 2009 Sep; 284(1-2):116-9. PubMed ID: 19428028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study.
    Horakova D; Dwyer MG; Havrdova E; Cox JL; Dolezal O; Bergsland N; Rimes B; Seidl Z; Vaneckova M; Zivadinov R
    J Neurol Sci; 2009 Jul; 282(1-2):112-9. PubMed ID: 19168190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood.
    Mikaeloff Y; Adamsbaum C; Husson B; Vallée L; Ponsot G; Confavreux C; Tardieu M; Suissa S;
    Brain; 2004 Sep; 127(Pt 9):1942-7. PubMed ID: 15289266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.